Ryan Specialty (NYSE:RYAN) Announces Earnings Results

Ryan Specialty (NYSE:RYAN) issued its earnings results on Thursday. The company reported $0.74 EPS for the quarter, beating analysts’ consensus estimates of $0.60 by $0.14, FiscalAI reports. Ryan Specialty had a return on equity of 41.33% and a net margin of 8.21%.The company had revenue of $916.65 million during the quarter, compared to the consensus estimate of $873.93 million. During the same period in the previous year, the firm posted $0.66 earnings per share. Ryan Specialty’s quarterly revenue was up 7.2% compared to the same quarter last year.

Here are the key takeaways from Ryan Specialty’s conference call:

• Second-quarter results exceeded expectations, with revenue up 7.2% to $917 million, organic growth of 6.7%, adjusted EBITDA up 6% to $327 million, and adjusted EPS up 12.1% to $0.74. First-half organic growth reached 8.9%, while management raised its full-year organic growth outlook to the higher end of the mid-single-digit range.
• Ryan Specialty repurchased 8.1 million shares for $260 million during the quarter, authorized an additional $300 million for buybacks, and repurchased another $42 million in July. Net leverage ended at 3.3 times, within management’s targeted 3-to-4-times range.
• The company expects continued pressure from declining property pricing, heightened competition in casualty and binding authority, builders-risk headwinds, and a difficult third-quarter comparison. Full-year adjusted EBITDA margin is now expected to decline approximately 50 to 100 basis points, reflecting talent investments, lower fiduciary income, and higher healthcare costs.
• Management highlighted strong performance in casualty construction, professional lines, transactional liability, and reinsurance, supported by a robust pipeline and continued specialty-market demand. Investments in AI, alternative capital solutions, benefits, and new underwriting businesses are intended to improve productivity, diversify revenue, and support longer-term growth.
• Management said it is unlikely to close a meaningful acquisition in 2026 and is instead evaluating opportunities for 2027, while maintaining a disciplined approach focused on strategic fit, cultural alignment, and accretion.

Ryan Specialty Stock Performance

Shares of NYSE RYAN traded down $2.42 during midday trading on Thursday, hitting $44.06. 2,593,910 shares of the company’s stock were exchanged, compared to its average volume of 1,943,053. Ryan Specialty has a twelve month low of $29.28 and a twelve month high of $61.85. The firm has a market cap of $11.62 billion, a P/E ratio of 22.67, a PEG ratio of 1.01 and a beta of 0.61. The stock’s 50 day moving average price is $37.29 and its 200-day moving average price is $38.44. The company has a debt-to-equity ratio of 2.90, a current ratio of 1.02 and a quick ratio of 1.02.

Insider Activity at Ryan Specialty

In other Ryan Specialty news, Chairman Patrick G. Ryan purchased 120,000 shares of the firm’s stock in a transaction dated Friday, June 5th. The stock was bought at an average price of $32.50 per share, with a total value of $3,900,000.00. Following the completion of the purchase, the chairman owned 13,817,859 shares in the company, valued at $449,080,417.50. This trade represents a 0.88% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director John W. Rogers, Jr. purchased 7,500 shares of the stock in a transaction dated Wednesday, June 10th. The shares were acquired at an average cost of $35.16 per share, for a total transaction of $263,700.00. Following the completion of the acquisition, the director directly owned 117,933 shares of the company’s stock, valued at approximately $4,146,524.28. This trade represents a 6.79% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired a total of 130,715 shares of company stock worth $4,263,590 in the last three months. 52.03% of the stock is owned by company insiders.

Hedge Funds Weigh In On Ryan Specialty

Institutional investors and hedge funds have recently bought and sold shares of the stock. Los Angeles Capital Management LLC bought a new stake in shares of Ryan Specialty during the 4th quarter worth about $25,000. Advisory Services Network LLC acquired a new position in shares of Ryan Specialty during the third quarter valued at approximately $28,000. Quarry LP bought a new stake in Ryan Specialty during the third quarter worth approximately $37,000. Caitong International Asset Management Co. Ltd raised its holdings in Ryan Specialty by 173.7% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 709 shares of the company’s stock worth $37,000 after purchasing an additional 450 shares in the last quarter. Finally, GW&K Investment Management LLC lifted its position in Ryan Specialty by 77.0% in the fourth quarter. GW&K Investment Management LLC now owns 876 shares of the company’s stock worth $45,000 after purchasing an additional 381 shares during the period. Institutional investors own 84.82% of the company’s stock.

Ryan Specialty announced that its board has authorized a share buyback plan on Tuesday, May 26th that allows the company to buyback $300.00 million in outstanding shares. This buyback authorization allows the company to reacquire up to 3.5% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s management believes its stock is undervalued.

Wall Street Analyst Weigh In

RYAN has been the topic of a number of research reports. Weiss Ratings reiterated a “sell (d+)” rating on shares of Ryan Specialty in a research report on Monday, May 4th. Piper Sandler upped their price objective on Ryan Specialty from $40.00 to $44.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 15th. Cantor Fitzgerald increased their target price on Ryan Specialty from $33.00 to $34.00 and gave the stock a “neutral” rating in a research report on Thursday, July 9th. The Goldman Sachs Group raised their target price on Ryan Specialty from $35.00 to $40.00 and gave the company a “neutral” rating in a research note on Wednesday, July 1st. Finally, Mizuho boosted their price target on shares of Ryan Specialty from $35.00 to $39.00 and gave the company a “neutral” rating in a report on Thursday, July 9th. Eight investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $50.00.

About Ryan Specialty

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.